What's New at CBER Update

["U.S. Food & Drug Administration (FDA)" <fda@xxxxxxxxxxxxxxxxxxxxxxx>]

Title: What's New at CBER Update

Having trouble viewing this email? View it as a Web page.

What's New at CBER

 

You are subscribed to What's New at CBER for the U.S. Food & Drug Administration (FDA).

This page has been updated recently.

• User Fee Billable Biologic Products and Potencies Approved Under Section 351 of the PHS Act
  Updated: 7/28/2017

---

Center for Biologics Evaluation and Research

Follow CBER on Twitter @FDACBER

Contact us at 1-800-835-4709 or ocod@xxxxxxxxxxx

---

Privacy Policy: http://www.fda.gov/privacy

Subscriber Services:
Manage Preferences  |  Unsubscribe  |  Help with this service

Stay Connected to FDA:

---

This email was sent to list-fda@xxxxxxxxxxx using GovDelivery Communications Cloud on behalf of: U.S. Food & Drug Administration (FDA) · 10903 New Hampshire Ave · Silver Spring, MD 20993 · 1-888-INFO-FDA (1-888-463-6332)